These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22851272)

  • 1. High-cost imaging in elderly patients with stage IV cancer: challenges for research, policy, and practice.
    Yabroff KR; Warren JL
    J Natl Cancer Inst; 2012 Aug; 104(15):1113-4. PubMed ID: 22851272
    [No Abstract]   [Full Text] [Related]  

  • 2. High-cost imaging in elderly patients with stage IV cancer.
    Hu YY; Kwok AC; Jiang W; Taback N; Loggers ET; Ting GV; Lipsitz SR; Weeks JC; Greenberg CC
    J Natl Cancer Inst; 2012 Aug; 104(15):1164-72. PubMed ID: 22851271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rising costs of medical imaging spur debate.
    Rowan K
    J Natl Cancer Inst; 2008 Dec; 100(23):1665-7. PubMed ID: 19033570
    [No Abstract]   [Full Text] [Related]  

  • 4. ["Check-up" offer to managers: is screening for early recognition of disease being discredited?].
    Riemann JF
    Dtsch Med Wochenschr; 2010 Apr; 135(16):812. PubMed ID: 20391313
    [No Abstract]   [Full Text] [Related]  

  • 5. Sixth Annual Mario S. Verani, MD Memorial Lecture: Cardiovascular imaging--added value or added cost?
    Bonow RO
    J Nucl Cardiol; 2008; 15(2):170-7. PubMed ID: 18371587
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].
    Plathow C; Walz M; Lichy MP; Aschoff P; Pfannenberg C; Bock H; Eschmann SM; Claussen CD; Schlemmer HP
    Radiologe; 2008 Apr; 48(4):384-96. PubMed ID: 17891370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of diagnostic medical imaging.
    Bradley D; Bradley KE
    N C Med J; 2014; 75(2):121-5. PubMed ID: 24663134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of PET and PET/computed tomography: a systematic review.
    Gerke O; Hermansson R; Hess S; Schifter S; Vach W; Høilund-Carlsen PF
    PET Clin; 2015 Jan; 10(1):105-24. PubMed ID: 25455883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sunset of the CT scan?
    Nakaji P
    World Neurosurg; 2010 Apr; 73(4):233-4. PubMed ID: 20849762
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnostic screening for cancer and coronary heart disease with radiological and nuclear imaging techniques: early diagnosis at any price?].
    Weltermann B; Hermann M; Gesenhues S
    Dtsch Med Wochenschr; 2010 Apr; 135(16):813-8. PubMed ID: 20391314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value analysis of postoperative staging imaging for asymptomatic, early-stage breast cancer: implications of clinical variation on utility and cost.
    Pellet AC; Erten MZ; James TA
    Am J Surg; 2016 Jun; 211(6):1084-8. PubMed ID: 26545344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of initial computed tomography angiography vs cardiac catheterization.
    Fleet S
    J Cardiovasc Comput Tomogr; 2007 Oct; 1(2):124; author reply 124. PubMed ID: 19083894
    [No Abstract]   [Full Text] [Related]  

  • 13. Does surveillance imaging after treatment for diffuse large B-cell lymphoma really work?
    Abel GA
    J Clin Oncol; 2015 May; 33(13):1427-9. PubMed ID: 25823731
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancing Value of MRI: A Call for Action.
    Anzai Y; Minoshima S; Lee VS
    J Magn Reson Imaging; 2019 Jun; 49(7):e40-e48. PubMed ID: 30431676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New challenges and perspectives in nuclear medicine imaging].
    Borbély K
    Magy Onkol; 2014 Dec; 58(4):232-8. PubMed ID: 25517440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications.
    De Placido S; De Angelis C; Giuliano M; Pizzi C; Ruocco R; Perrone V; Bruzzese D; Tommasielli G; De Laurentiis M; Cammarota S; Arpino G; Arpino G
    Br J Cancer; 2017 Mar; 116(6):821-827. PubMed ID: 28170371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
    Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
    Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based imaging in lung cancer: a systematic review.
    Ravenel JG
    J Thorac Imaging; 2012 Sep; 27(5):315-24. PubMed ID: 22914125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gray zones of privatized imaging.
    Lau PW; Illes J
    Am J Bioeth; 2009 Apr; 9(4):21-2. PubMed ID: 19326305
    [No Abstract]   [Full Text] [Related]  

  • 20. The current and future use of tumor-localizing agents.
    Davis M
    J Nucl Med; 1990 Oct; 31(10):1658-61. PubMed ID: 2213189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.